Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 117

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 117
---
 specific period of time, all at the discretion of the board of directors. Further, NLS is a foreign private issuer and, as such, is eligible for an exemption from certain Nasdaq corporate governance requirements that apply to issuers that are not foreign private issuers. A discussion of any material differences in the corporate laws of Israel and Switzerland please see the section entitled “ The Merger Agreement — Governance of the Combined Company after the Merger.” 16 Share Ownership of NLS Directors and Executive Officers As of July 9, 2025, NLS’s directors and executive officers as a group, owned and were entitled to vote 502,101 NLS Common Shares, or 12.1% of the outstanding NLS Common Shares. The directors and executive officers have informed us that they intend to vote all of their NLS Common Shares “FOR”the approval of the Merger. Share Ownership of Kadimastem Directors and Executive Officers As of July 9, 2025, Kadimastem’s directors and executive officers as a group, owned and were entitled to vote 1,761,141 Kadimastem Ordinary Shares on a fully diluted basis, or 24.65% of the outstanding Kadimastem Ordinary Shares on a fully diluted basis. The Merger has been approved by the shareholders of Kadimastem. Termination of the Merger Agreement (Page 160) The Merger Agreement contains customary termination rights for each of NLS and Kadimastem, including the right of NLS and Kadimastem to terminate the Merger Agreement if the Closing shall not have occurred on or before August 31, 2025, which outside date can be extended by mutual agreement. The Merger Agreement also provides that NLS shall pay to Kadimastem a termination fee of $10,000,000 plus the NLS Operating Expenses (as defined in the Merger Agreement), up to a maximum of $250,000 per month beginning July 28, 2024, and the Transaction Expenses (as defined in the Merger Agreement) if NLS terminates the Merger Agreement prior to obtaining the Parent Requisite Vote (as defined in the Merger Agreement) to enter into a definitive agreement providing for a Parent Superior Proposal (as defined in the Merger Agreement) in accordance with terms of the Merger Agreement. Related Agreements (Page 162) Contingent Value Right Agreement Prior to the Closing, NLS will enter into the CVR Agreement with VStock Transfer